Cargando…
Neurophysiological Biomarkers of Parkinson’s Disease
BACKGROUND: There is a need for reliable and robust Parkinson’s disease biomarkers that reflect severity and are sensitive to disease modifying investigational therapeutics. OBJECTIVE: To demonstrate the utility of EEG as a reliable, quantitative biomarker with potential as a pharmacodynamic endpoin...
Autores principales: | Waninger, Shani, Berka, Chris, Stevanovic Karic, Marija, Korszen, Stephanie, Mozley, P. David, Henchcliffe, Claire, Kang, Yeona, Hesterman, Jacob, Mangoubi, Tomer, Verma, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242849/ https://www.ncbi.nlm.nih.gov/pubmed/32116262 http://dx.doi.org/10.3233/JPD-191844 |
Ejemplares similares
-
Event-related potentials during sustained attention and memory tasks: Utility as biomarkers for mild cognitive impairment
por: Waninger, Shani, et al.
Publicado: (2018) -
Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease
por: Kang, Yeona, et al.
Publicado: (2018) -
Comparison of Medical and Consumer Wireless EEG Systems for Use in Clinical Trials
por: Ratti, Elena, et al.
Publicado: (2017) -
Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021) -
EEG event related potentials in sustained, focused and divided attention tasks: Potential biomarkers for cognitive impairment in HIV patients
por: Meghdadi, Amir H., et al.
Publicado: (2021)